Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05301114 · ClinicalTrials.gov registry record · NA
Social Risk Factors and Discrimination in Cancer Survivorship
A NA study of Breast Cancer and Prostate Cancer, sponsored by Medstar Health Research Institute.
- Active
- Registry status
- NA
- Development phase
- 1,116
- Enrollment target
- 1
- Study location
NCT05301114: Active NA study of Breast Cancer and Prostate Cancer, sponsored by Medstar Health Research Institute.
NCT05301114 is a NA study of Breast Cancer and Prostate Cancer that is active but no longer recruiting, run by Medstar Health Research Institute. The registered enrollment target is 1,116 participants, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05301114, a NA study of Breast Cancer and Prostate Cancer, is active but no longer recruiting, sponsored by Medstar Health Research Institute.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 1,116 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of the proposed study is to scale social risk factor screening and referral for cancer survivors and to solidify information exchange between clinical and community settings in order to improve survivor health and well-being. This will be completed through three primary aims: 1) To ascertain workflow and map community resources needed to facilitate social risk factor screening and referral for breast and prostate cancer survivors in Washington, District of Columbia. 2) To determine impact of Community Health Worker (CHW) support on Black breast and prostate cancer survivor health and wellbeing as measured through quality of life (QOL) and social connection. 3) To determine impact of anti-racism training for staff and clinicians at three cancer centers on patient-reported discrimination.
Primary Outcome
This study will use the following Patient-Reported Outcomes Measurement Information System® (PROMIS) self-efficacy for managing chronic conditions 4-item measures: managing daily activities, managing emotions, managing medications and treatments, and managing social interactions. The minimum score on these overall scales is a 16 and the maximum score is 80, in which a higher number represents a higher level of self-efficacy for managing chronic conditions. PROMIS raw scores are then transformed
Conditions Studied
Interventions
- BEHAVIORAL Community Health Worker support
Study Locations (1)
District of Columbia
- MedStar Washington Hospital Center - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,116 participants |
| Start Date | 2022-05-05 |
| Est. Completion | 2026-09-30 |
| Phase | NA |
What the registry record for NCT05301114 still lists
NCT05301114 is an interventional study that assigns participants to a tested intervention. Its 1,116 participants enrollment target places it among the larger protocols in the corpus, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (60% lower).
The record links to 5 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Community Health Worker support is the first listed.
NCT05301114 reports a single indexed study location in District of Columbia.
Frequently Asked Questions
What is clinical trial NCT05301114 about?
NCT05301114 is a clinical study titled "Social Risk Factors and Discrimination in Cancer Survivorship". The objective of the proposed study is to scale social risk factor screening and referral for cancer survivors and to solidify information exchange between clinical and community settings in order to improve survivor health and well-being. This will be completed through three primary aims: 1) To asc...
What is the current status of trial NCT05301114?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,116 participants. The study started on 2022-05-05. Estimated completion is 2026-09-30.
What conditions does trial NCT05301114 study?
This clinical trial studies the following conditions: Breast Cancer, Prostate Cancer, Social Determinants of Health, Health Equity, Disparities.
What interventions are being tested in trial NCT05301114?
The interventions under investigation include: Community Health Worker support (BEHAVIORAL).
Who is sponsoring clinical trial NCT05301114?
This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05301114 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05301114's enrollment target sits among peer trials
1,116 111th of 1224 higher than 1,114 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02140255 · 1,120 participants · Phase 1
Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
- NCT06618534 · 1,120 participants · Phase 2
Azithromycin for Meningococcal Carriage
- NCT07164131 · 1,120 participants · Phase 4
Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With Beta-lactams
- NCT05691478 · 1,122 participants · Phase 2
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI